BioSpace News Archive

Genetown

CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX110™ for the Treatment of Relapsed or Refractory CD19+ B-cell malignancies

CRISPR Therapeutics (Nasdaq: CRSP), today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX110™, its wholly-owned allogeneic CAR-T cell therapy targeting CD19+ B-cell malignancies.

November 22, 2021
·
5 min read
BioMidwest

POINT Biopharma to Host Virtual Education Event on December 6, 2021

POINT Biopharma Global Inc. today announced that it will host a virtual education event titled “The First Principles of Radiopharmaceuticals” on Monday, December 6, 2021 at 12:00 pm ET.

November 22, 2021
·
1 min read
Genetown

Infinity to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

Infinity to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

November 22, 2021
·
2 min read
Genetown

Moderna to Present at Upcoming Investor Conferences in December 2021

Moderna, Inc. today announced its participation in the following upcoming virtual investor conferences: NASDAQ 45th Investor Conference on Wednesday, December 1st at 9:30 a.m. ET.

November 22, 2021
·
1 min read
Drug Development

Promising COVID-19 Therapeutic Drug to start Phase 3 Clinical Trial in the United StatesPulmonem and the Research Institute of the McGill University Health Centre announce recruitment of first US-based patients

Pulmonem Inc. and the Research Institute of the McGill University Health Centre today announced that they have successfully started recruiting US-based patients for the Phase 3 Clinical Trial (ClinicalTrials.gov Identifier: NCT04935476) of the promising COVID-19 therapeutic drug PULM-001.

November 22, 2021
·
3 min read
Izotropic’s Breast CT Radiation Imaging Subsystem Powered on and Takes Initial Images

IzoView radiation imaging subsystem assembly, functionality, and installation features.

November 22, 2021
·
5 min read
Biotech Beach

LIXTE BIOTECHNOLOGY HOLDINGS, INC. ANNOUNCES THAT ENROLLMENT HAS RESUMED IN NATIONAL CANCER INSTITUTE’S TRIAL TO DETERMINE ABILITY OF LIXTE COMPOUND LB-100 TO ENTER RECURRENT, MALIGNANT BRAIN TUMORS

Lixte Biotechnology Holdings, Inc . announced that the National Cancer Institute (NCI) has resumed enrolling patients into their pharmacologic study of the ability of Lixte’s lead compound, LB-100, to enter the brain and penetrate recurrent, malignant brain tumors, in patients where surgical removal of their cancer is indicated.

November 22, 2021
·
5 min read
Le Bonheur first in region to perform pulmonary valve replacement for tetralogy of Fallot via catheterization using newly FDA-approved Harmony valve

But thanks to a new device – the Harmony Transcatheter Pulmonary Valve (TPV) system – Le Bonheur Medical Director of the Interventional Catheterization Laboratory Shyam Sathanandam, MD, can conduct pulmonary valve replacement for TOF patients through a minimally-invasive catheterization procedure.

November 22, 2021
·
5 min read
Drug Development

Arctic Vision Announces First Patient Dosed in Phase III Study of ARVN001 for Treatment of Macular Edema Associated with Uveitis (UME)

Arctic Vision, a China-based biotech company focused on innovative ophthalmic therapies, announced on Nov. 19 that the first set of patients have been dosed in the Phase III study of ARVN001 (triamcinolone acetonide suprachoroidal injectable suspension, known as XIPERE™ in the U.S.) for the treatment of macular edema associated with uveitis (UME) in China.

November 22, 2021
·
5 min read
Business

Pharnext Appoints Dr. Burkhard Blank as New Chief Medical Officer and Head of Research & Development

Pharnext SA announces the appointment of Dr. Burkhard Blank as Chief Medical Officer and Head of Research & Development effective January 1, 2022.

November 22, 2021
·
6 min read